Can low-dose naltrexone stop gallbladder flares?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Low-Dose Naltrexone for Gallbladder Flares: Not an Established Treatment

Low-dose naltrexone is not indicated for gallbladder flares and has no established role in preventing or treating acute cholecystitis or biliary colic. The evidence for naltrexone relates exclusively to cholestatic pruritus (itching from bile duct diseases), not gallbladder inflammation or pain.

Why This Confusion Exists

Naltrexone appears in hepatobiliary guidelines, but only for a very specific indication:

  • Naltrexone is recommended as third-line treatment for cholestatic pruritus in conditions like primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), not for gallbladder disease 1, 2, 3, 4
  • The European Association for the Study of the Liver (EASL) recommends naltrexone 50 mg daily (starting at 25 mg) only after cholestyramine and rifampicin have failed for pruritus management 1
  • British Society of Gastroenterology guidelines similarly position naltrexone (12.5-50 mg daily) as second-line treatment for pruritus in PSC, not for gallbladder symptoms 2, 3

What Naltrexone Actually Does

The mechanism of naltrexone in cholestatic conditions involves:

  • Blocking opioid receptors that may be involved in the sensation of itching from accumulated bile acids in cholestatic liver diseases 1, 4
  • This has nothing to do with gallbladder inflammation, gallstone formation, or biliary colic 1
  • Low-dose naltrexone (1.5-4.5 mg) has been studied for neuropathic pain and inflammatory conditions, but not gallbladder disease 5, 6, 7

Common Side Effects That Could Worsen Gallbladder Symptoms

Naltrexone can cause gastrointestinal side effects that might be confused with or exacerbate gallbladder symptoms:

  • Abdominal pain/cramps, nausea, and vomiting occur in >10% of patients taking naltrexone 8
  • These symptoms overlap with gallbladder flare presentations, making naltrexone a poor choice for this indication 8
  • Withdrawal-like symptoms (including abdominal cramps) can occur when starting naltrexone, even in opioid-free individuals 8, 9

What Actually Works for Gallbladder Flares

For acute cholecystitis or symptomatic cholelithiasis:

  • Definitive treatment is cholecystectomy (surgical removal) or EUS-guided gallbladder drainage in high-risk surgical patients 10
  • EUS-guided gallbladder drainage shows 95.8% technical success and 94.3% clinical success with only 4.2% recurrence at ≥1 year follow-up 10
  • Ursodeoxycholic acid (UDCA) may help prevent gallstone formation during rapid weight loss, but is not a treatment for acute flares 11
  • Pain management during acute episodes uses acetaminophen (up to 3 g/day) as first-line, with opioids reserved for severe pain 12

Critical Distinction: Cholestatic Pruritus vs. Gallbladder Disease

The evidence base is clear:

  • Cholestatic pruritus = itching from bile duct obstruction in diseases like PBC/PSC → naltrexone may help 1, 3, 4
  • Gallbladder flares = acute cholecystitis or biliary colic from gallstones → naltrexone has no role 10
  • Studies showing naltrexone efficacy for pruritus in biliary atresia and cholestatic patients do not translate to gallbladder inflammation 13, 9

Hepatotoxicity Concerns

An important safety consideration:

  • High-dose naltrexone (up to 300 mg/day) causes hepatocellular injury in a substantial proportion of patients 8
  • While standard doses (50 mg) and low doses (1.5-4.5 mg) appear safer, any hepatotoxicity risk is unacceptable for an indication without evidence 8, 14
  • Naltrexone should be used with caution in hepatic impairment and avoided in severe hepatic impairment (Child-Pugh >9) 11

References

Research

Low-dose naltrexone for treatment of dermatologic conditions: A clinical review.

Journal of the American Academy of Dermatology, 2026

Research

Effect of oral naltrexone on pruritus in cholestatic patients.

World journal of gastroenterology, 2006

Guideline

american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.